Citigroup’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$465K Hold
750,000
﹤0.01% 3593
2025
Q4
$885K Hold
750,000
﹤0.01% 3213
2025
Q3
$1.12M Hold
750,000
﹤0.01% 3093
2025
Q2
$1.46M Hold
750,000
﹤0.01% 2924
2025
Q1
$915K Hold
750,000
﹤0.01% 3309
2024
Q4
$2.27M Hold
750,000
﹤0.01% 2718
2024
Q3
$1.9M Buy
750,000
+747,814
+34,209% +$2.66M ﹤0.01% 2710
2024
Q2
$10.3K Sell
2,186
-483
-18% -$2.55K ﹤0.01% 5136
2024
Q1
$15.1K Buy
2,669
+309
+13% +$2.04K ﹤0.01% 5107
2023
Q4
$15.6K Buy
2,360
+2,353
+33,614% +$13.6K ﹤0.01% 5070
2023
Q3
$56 Sell
7
-4,719
-100% -$43.9K ﹤0.01% 5514
2023
Q2
$47.9K Sell
4,726
-22,141
-82% -$226K ﹤0.01% 4669
2023
Q1
$286K Buy
26,867
+9,621
+56% +$106K ﹤0.01% 3527
2022
Q4
$198K Buy
+17,246
New +$155K ﹤0.01% 3724
2022
Q2
Sell
-171
Closed -$2K 6658
2022
Q1
$2K Buy
+171
New +$2.07K ﹤0.01% 6098
2021
Q3
Sell
-1
Closed 6289
2021
Q2
$0 Sell
1
-454
-100% -$6.22K ﹤0.01% 6395
2021
Q1
$7K Sell
455
-735
-62% -$11.1K ﹤0.01% 5816
2020
Q4
$18K Buy
1,190
+861
+262% +$14K ﹤0.01% 6724
2020
Q3
$5K Sell
329
-393
-54% -$5.52K ﹤0.01% 7045
2020
Q2
$9K Buy
722
+375
+108% +$4.92K ﹤0.01% 7104
2020
Q1
$3K Buy
+347
New +$4.69K ﹤0.01% 7386

Other funds holding TELA

Citigroup's TELA Position: Q1 2026 in Review

Citigroup held its TELA Bio (TELA) position steady in Q1 2026 at 750,000 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Citigroup first reported a position in TELA in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.27M in Q4 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Citigroup held 750,000 shares of TELA Bio worth $465K as of Q1 2026.
  • Citigroup left its TELA Bio share count unchanged in Q1 2026.
  • TELA Bio made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3593 holding.
  • Citigroup first reported a position in TELA Bio in Q1 2020 and has held it in 21 quarters since.
  • Citigroup's TELA Bio position peaked at $2.27M in Q4 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.